We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOLE:NYSEDole plc Analysis

Data as of 2026-09-01 - not real-time

$13.85

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

At $13.85, Dole plc shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 2.9% over the past 30 days. With RSI at 55.6 the momentum picture is neutral, alongside a bullish MACD signal. Watch $12.74 as support and $14.16 as the nearer resistance level.
Valuation screens as undervalued, on a P/E of 18.7 with no clean sector comparison available. Sell-side targets cluster 25.9% above the current quote. Revenue is growing at 2.9% on a 0.6% profit margin. The 2.47% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 28.9%, a beta of -0.04 and a maximum drawdown of 21.1%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

Dole plc NYSE:DOLE shares fell more than 4% in premarket trading on Monday after the fresh produce group reported...Hosted on MSN22dDole shares fall 5% after Q2 earnings and revenue miss expectationsDole plc NYSE:DOLE shares dropped 5.Hosted on MSN22dDole shares fall 5% after Q2 earnings and revenue miss expectationsDole plc NYSE:DOLE shares dropped 5.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 14.60
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 14.60
  • Analyst targets imply +25.9% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +25.9% versus the current price
  • P/E ratio of 18.7
  • Dividend yield of 2.47%

Key Metrics & Analysis

Financial Health

Revenue Growth2.90%
Profit Margin0.63%
P/E Ratio18.7
ROE6.93%
ROA2.55%
Debt/Equity98.64
P/B Ratio1.0
Op. Cash Flow$169.3M
Free Cash Flow$149.6M

Technical Analysis

TrendBearish
RSI55.6
Support$12.74
Resistance$14.16
MA 20$13.44
MA 50$13.84
MA 200$14.60
MACDBullish
VolumeDecreasing
Fear & Greed Index93.16

Valuation

Fair Value$10.68
Target Price$17.44
Upside/Downside25.90%
GradeUndervalued
TypeValue
Dividend Yield2.47%

Risk Assessment

Beta-0.04
Volatility28.95%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.